US Stock MarketDetailed Quotes

ENSC Ensysce Biosciences

Watchlist

0.4350
-0.0268-5.80%

Close Jul 19 16:00 ET

0.4340
-0.0010-0.23%

Post 17:15 ET

3.30MMarket Cap-137P/E (TTM)

Ensysce Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

5.50%-3.41M

39.73%-10.78M

45.33%-1.8M

66.30%-2.26M

30.00%-3.11M

-4.94%-3.61M

-117.02%-17.89M

12.53%-3.3M

-75.54%-6.71M

-3,256.08%-4.44M

Net income from continuing operations

-42.19%-3.12M

56.10%-10.63M

36.03%-3.5M

72.70%-2.69M

71.74%-2.24M

-130.49%-2.19M

16.94%-24.21M

45.42%-5.48M

42.70%-9.86M

-694.21%-7.92M

Operating gains losses

95.91%-8.96K

95.78%-283.96K

99.92%-4.09K

-101.63%-17.22K

70.60%-43.62K

92.17%-219.03K

-145.65%-6.74M

-240.02%-4.84M

-91.19%1.05M

79.18%-148.39K

Other non cash items

926.56%1.2M

-95.84%344.65K

-91.76%482.12K

-99.70%7.6K

-100.00%-44

86.18%-145.03K

13.13%8.29M

27.84%5.85M

117.15%2.5M

-20.86%995.01K

Change In working capital

-29.67%-1.51M

-117.28%-947.08K

-73.01%742K

167.25%382.11K

-138.58%-902.99K

-221.69%-1.17M

520.55%5.48M

254.36%2.75M

-347.51%-568.2K

722.74%2.34M

-Change in receivables

110.70%1.34K

8.71%179.26K

107.48%10.18K

-100.12%-160

-65.84%181.73K

96.60%-12.49K

137.33%164.9K

61.67%-136.01K

1,279.69%135.82K

805.96%531.97K

-Change in prepaid assets

-135.74%-86.7K

-15.77%1.39M

-86.67%156.93K

20.80%765.85K

130.64%226.81K

-58.31%242.59K

202.27%1.65M

226.24%1.18M

180.59%634K

-1,523.70%-740.34K

-Change in payables and accrued expense

-2.23%-1.43M

-168.73%-2.52M

-66.35%574.89K

71.33%-383.58K

-151.46%-1.31M

-287.70%-1.4M

385.80%3.66M

445.84%1.71M

-230.18%-1.34M

728.02%2.55M

Cash from discontinued investing activities

Operating cash flow

5.50%-3.41M

39.73%-10.78M

45.33%-1.8M

66.30%-2.26M

30.00%-3.11M

-4.94%-3.61M

-117.02%-17.89M

12.53%-3.3M

-75.54%-6.71M

-3,256.08%-4.44M

Investing cash flow

Cash flow from continuing investing activities

4.5K

Net other investing changes

----

--4.5K

--0

Cash from discontinued investing activities

Investing cash flow

----

--0

----

--4.5K

--0

Financing cash flow

Cash flow from continuing financing activities

203.42%5.69M

-0.11%8.76M

-24.70%1.46M

-101.37%-102.46K

2,177.51%5.52M

579.20%1.87M

-56.85%8.77M

-78.88%1.94M

181.43%7.48M

-103.38%-265.81K

Net issuance payments of debt

-16.81%-485.19K

-90.12%605.43K

240.53%1.61M

--0

-120.03%-584.86K

---415.35K

-55.97%6.13M

-112.05%-1.14M

86.85%7.53M

-631.62%-265.81K

Net common stock issuance

--0

139.21%9.05M

--0

--6.36M

--2.69M

-42.91%3.78M

--3.78M

--0

Proceeds from stock option exercised by employees

--6.33M

----

--0

----

Net other financing activities

61.46%-153.68K

21.29%-899.55K

79.37%-144.54K

-100.23%-102.46K

---253.84K

-1.90%-398.72K

-133.94%-1.14M

-138.96%-700.45K

---51.17K

--0

Cash from discontinued financing activities

Financing cash flow

203.42%5.69M

-0.11%8.76M

-24.70%1.46M

-101.37%-102.46K

2,177.51%5.52M

579.20%1.87M

-56.85%8.77M

-78.88%1.94M

181.43%7.48M

-103.38%-265.81K

Net cash flow

Beginning cash position

-64.30%1.12M

-74.34%3.15M

-67.48%1.46M

2.54%3.83M

-83.23%1.42M

-74.34%3.15M

6,215.06%12.26M

-34.22%4.5M

-53.39%3.73M

2,811.41%8.44M

Current changes in cash

231.69%2.28M

77.80%-2.02M

74.86%-340.78K

-407.78%-2.37M

151.29%2.41M

54.71%-1.73M

-175.53%-9.12M

-125.01%-1.36M

165.90%768.44K

-160.95%-4.71M

End cash Position

140.46%3.4M

-64.30%1.12M

-67.48%1.46M

2.54%3.83M

-83.23%1.42M

-74.34%3.15M

-34.22%4.5M

-53.39%3.73M

Free cash flow

5.50%-3.41M

39.73%-10.78M

45.33%-1.8M

66.30%-2.26M

30.00%-3.11M

-4.94%-3.61M

-117.02%-17.89M

12.53%-3.3M

-75.54%-6.71M

-3,256.08%-4.44M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	5.50%-3.41M	39.73%-10.78M	45.33%-1.8M	66.30%-2.26M	30.00%-3.11M	-4.94%-3.61M	-117.02%-17.89M	12.53%-3.3M	-75.54%-6.71M	-3,256.08%-4.44M
Net income from continuing operations	-42.19%-3.12M	56.10%-10.63M	36.03%-3.5M	72.70%-2.69M	71.74%-2.24M	-130.49%-2.19M	16.94%-24.21M	45.42%-5.48M	42.70%-9.86M	-694.21%-7.92M
Operating gains losses	95.91%-8.96K	95.78%-283.96K	99.92%-4.09K	-101.63%-17.22K	70.60%-43.62K	92.17%-219.03K	-145.65%-6.74M	-240.02%-4.84M	-91.19%1.05M	79.18%-148.39K
Other non cash items	926.56%1.2M	-95.84%344.65K	-91.76%482.12K	-99.70%7.6K	-100.00%-44	86.18%-145.03K	13.13%8.29M	27.84%5.85M	117.15%2.5M	-20.86%995.01K
Change In working capital	-29.67%-1.51M	-117.28%-947.08K	-73.01%742K	167.25%382.11K	-138.58%-902.99K	-221.69%-1.17M	520.55%5.48M	254.36%2.75M	-347.51%-568.2K	722.74%2.34M
-Change in receivables	110.70%1.34K	8.71%179.26K	107.48%10.18K	-100.12%-160	-65.84%181.73K	96.60%-12.49K	137.33%164.9K	61.67%-136.01K	1,279.69%135.82K	805.96%531.97K
-Change in prepaid assets	-135.74%-86.7K	-15.77%1.39M	-86.67%156.93K	20.80%765.85K	130.64%226.81K	-58.31%242.59K	202.27%1.65M	226.24%1.18M	180.59%634K	-1,523.70%-740.34K
-Change in payables and accrued expense	-2.23%-1.43M	-168.73%-2.52M	-66.35%574.89K	71.33%-383.58K	-151.46%-1.31M	-287.70%-1.4M	385.80%3.66M	445.84%1.71M	-230.18%-1.34M	728.02%2.55M
Cash from discontinued investing activities
Operating cash flow	5.50%-3.41M	39.73%-10.78M	45.33%-1.8M	66.30%-2.26M	30.00%-3.11M	-4.94%-3.61M	-117.02%-17.89M	12.53%-3.3M	-75.54%-6.71M	-3,256.08%-4.44M
Investing cash flow
Cash flow from continuing investing activities		0	0	0			4.5K	0	0	0
Net other investing changes	----	----	----	----	----	----	--4.5K	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	----	--0	--0	--0	----	----	--4.5K	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	203.42%5.69M	-0.11%8.76M	-24.70%1.46M	-101.37%-102.46K	2,177.51%5.52M	579.20%1.87M	-56.85%8.77M	-78.88%1.94M	181.43%7.48M	-103.38%-265.81K
Net issuance payments of debt	-16.81%-485.19K	-90.12%605.43K	240.53%1.61M	--0	-120.03%-584.86K	---415.35K	-55.97%6.13M	-112.05%-1.14M	86.85%7.53M	-631.62%-265.81K
Net common stock issuance	--0	139.21%9.05M	--0	--0	--6.36M	--2.69M	-42.91%3.78M	--3.78M	--0	--0
Proceeds from stock option exercised by employees	--6.33M	----	----	----	----	--0	----	----	----	----
Net other financing activities	61.46%-153.68K	21.29%-899.55K	79.37%-144.54K	-100.23%-102.46K	---253.84K	-1.90%-398.72K	-133.94%-1.14M	-138.96%-700.45K	---51.17K	--0
Cash from discontinued financing activities
Financing cash flow	203.42%5.69M	-0.11%8.76M	-24.70%1.46M	-101.37%-102.46K	2,177.51%5.52M	579.20%1.87M	-56.85%8.77M	-78.88%1.94M	181.43%7.48M	-103.38%-265.81K
Net cash flow
Beginning cash position	-64.30%1.12M	-74.34%3.15M	-67.48%1.46M	2.54%3.83M	-83.23%1.42M	-74.34%3.15M	6,215.06%12.26M	-34.22%4.5M	-53.39%3.73M	2,811.41%8.44M
Current changes in cash	231.69%2.28M	77.80%-2.02M	74.86%-340.78K	-407.78%-2.37M	151.29%2.41M	54.71%-1.73M	-175.53%-9.12M	-125.01%-1.36M	165.90%768.44K	-160.95%-4.71M
End cash Position	140.46%3.4M	-64.30%1.12M	-64.30%1.12M	-67.48%1.46M	2.54%3.83M	-83.23%1.42M	-74.34%3.15M	-74.34%3.15M	-34.22%4.5M	-53.39%3.73M
Free cash flow	5.50%-3.41M	39.73%-10.78M	45.33%-1.8M	66.30%-2.26M	30.00%-3.11M	-4.94%-3.61M	-117.02%-17.89M	12.53%-3.3M	-75.54%-6.71M	-3,256.08%-4.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall